Abstract Library
Welcome to the open-access search for all ENETS abstracts presented at the Annual ENETS Conferences.
Everyone can browse the library to find basic information on abstracts. To get full access to each entry, you will be asked to log in to your myENETS account.
ENETS Abstract Search
Introduction: The pathogenesis of mesenteric fibrosis in small intestinal neuroendocrine tumours (SI-NETs) is poorly understood, limiting development of effective treatments and biomarkers. A major barrier to research is the lack of disease models.
Conference:
Presenting Author:
Authors: Hodgetts H, Martins M, Luong T, Hall A, Webster A,
Keywords: small intestine, neuroendocrine, 3D model, hydrogel, fibrosis,
#4637 Non-functional retroperitoneal paraganglioma in a young patient: A case report
Introduction: Paragangliomas are neuroendocrine tumours arising in the parasympathetic nervous system, outside the adrenal gland. Retroperitoneal location is extremely rare. Non-functional paragangliomas often represent a diagnostic challenge.
Conference:
Presenting Author:
Authors: Aris H, Saidi M, Lahfa I,
Keywords: retroperitoneal paraganglioma, surgery, monitoring,
#4617 Analysis of new immunohistochemical biomarkers in a cohort of pancreatic NETs
Introduction: Pancreatic neuroendocrine tumours (PanNETs) are rare diseases with a 10-year survival rate of only 40-50%. The ATRX, DAXX and ARX, PDX1 expressions in PanNETs were considered poor prognostic factors in some studies, but inconsistent in others.
Conference:
Presenting Author:
Authors: Ciobanu O, Martin S, Herlea V, Vasilescu F, Balaban D,
Keywords: Pancreatic neuroendocrine tumour, ATRX, DAXX, ARX, PDX1,
Introduction: Somatostatin receptors (SSTRs) expression in cohort of thoracic neuroendocrine neoplasms (NENs) is still not fully described. We attempted to evaluate the SSTR expression by IHC and PET/CT with Ga68 DOTA-TATE, as well as the sensitivity of both methods.
Conference:
Presenting Author: Evdokimova E
Authors: Evdokimova E, Vorobeva M, Zhulikov Y, Markovich A, Gorbunova V,
Keywords: NEN, thoracic, SSTR, IHC, DOTATATE, lung, thymus, mediastinum, LCNC, NET,
Introduction: In the ZS001 clinical trial, we observed that NET patients with higher PD-L1 expression levels were more likely to benefit preferentially from immunotherapy.
Conference:
Presenting Author:
Authors: Sun Y, Zhang Q, Cao F, Huang X, Zhang P,
Keywords: neuroendocrine tumour, immunotherapy, PD-L1, SP142, 28-8, C0148, E1L3N,